Specialty Equity Research and Professional Trading Service

Trades fully vetted with in-depth research based on a 3-pronged approach:
Fundamentals, Technicals and Options Activity

Welcome  Jags!

Our mission is to deliver actionable, timely, fundamentally driven equity research to help you outperform the broader market. Our trading is based on a specific, tried-and-true approach that consistently delivers results. Read more about our methods.

You will receive top of the line research and market information, along with specific trade recommendations. Check out the subscription page for more details, and please read a welcome letter from Fahad Khalid, Chief Executive Officer.


For more research notes like these, sign-up for our free weekly newsletter, JaguarResearch.

October 4, 2022 | 10:16 PM by Jay Kunstman

Neurocrine Biosciences (NBIX) – The Ingrezza Impact

Covered this morning in Conversations, Neurocrine Biosciences (NBIX) is a biotech focused on advance medicines for neurology, neuroendocrinology and neuropsychiatry-related disorders and diseases. The company’s commercially available products include Ingrezza,…

Continue Reading »

September 12, 2022 | 10:01 PM by Jay Kunstman

Inari Medical (NARI) – A Busy Week Ahead

Discussed this morning in Conversations, Inari Medical (NARI) is a medtech company focused on products for patients suffering from venous diseases. The company’s main products include ClotTriever for treatment of…

Continue Reading »

September 8, 2022 | 12:24 PM by Jay Kunstman

Axonics (AXNX) – Charging Along with F15

It’s been several months since we’ve mentioned shares of Axonics (AXNX), but decided to bring it up in Conversations this morning. Axonics is a medtech company that offers a sacral…

Continue Reading »

August 31, 2022 | 11:50 AM by Jay Kunstman

Sanara MedTech (SMTI) – Will Growth acCELLERATE?

It’s been over a year since we’ve covered this small cap medtech, so with recent earnings out of the way coupled with solid share performance, I thought I would refresh…

Continue Reading »

August 24, 2022 | 12:00 PM by Jay Kunstman

Biotech Check-Up (ARQT, CTIC, MIRM)

Throughout 2022, from W/E Research reports to Home Page write-ups to discussions in Conversations, the following three biotech stocks have been mentioned: Arcutis Biotherapeutics (ARQT), CTI Biopharma (CTIC), and Mirum…

Continue Reading »

Read more articles

Password must meet the following requirements: